The Postantifungal Effect (PAFE) of Itraconazole, in Comparison with Those of Miconazole and Fluconazole, on Candida Species

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Microbiology and immunology

• Publication date

  2006-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1348-0421.2006.tb03840.xPMID 16985289
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current Management of Fungal Infections

  2012cited by this paper
• Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard

  2008cited by this paper
• The in vitro post-antifungal effect of nystatin on Candida species of oral origin.

  2007cited by this paper
• Oral fungal infections.

  2005cited by this paper
• A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans.

  2004cited by this paper
• A Novel Murine Model of Oral Candidiasis with Local Symptoms Characteristic of Oral Thrush

  2003cited by this paper
• Postantifungal effect and effects of sub-MIC concentrations on previously treated Candida sp. influence of growth phase.

  2002cited by this paper
• Post-antifungal Effect and Effects of Sub-MIC Concentrations on Previously Treated Candida Spp.: Influence of Exposure Time and Concentration

  2002cited by this paper
• New Automated Method for Determining Postantifungal Effect of Amphotericin B against Candida Species: Effects of Concentration, Exposure Time, and Area under the Curve

  2002cited by this paper
• Reference method for broth dilution antifungal susceptibility testing of yeasts, Approved standard-second edition

  2002cited by this paper
• Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.

  2001cited by this paper
• Effects of Two Different Growth Media on the Postantifungal Effect Induced by Polyenes on Candida Species

  2001cited by this paper
• Effects of Two Different Growth Media on the Postantifungal Effect Induced by Polyenes on CandidaSpecies

  2001cited by this paper
• Pharmacology of itraconazole.

  2001cited by this paper
• In vitro pharmacodynamic characteristics of flucytosine determined by time-kill methods.

  2000cited by this paper
• Influence of pH and concentration on the postantifungal effect and on the effects of sub-MIC concentrations of 4 antifungal agents on previously treated Candida spp.

  2000cited by this paper
• Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE) and depresses the cell surface hydrophobicity of oral Candida albicans isolates.

  2000cited by this paper
• Once Daily Aminoglycoside Therapy

  1999cited by this paper
• Activity of voriconazole: post-antifungal effect, effects of low concentrations and of pretreatment on the susceptibility of Candida albicans to leucocytes.

  1999cited by this paper
• Itraconazole cyclodextrin solution: the role of in vitro susceptibility testing in predicting successful treatment of HIV‐related fluconazole‐resistant and fluconazole‐susceptible oral candidosis

  1997cited by this paper
• Itraconazole cyclodextrin solution for fluconazole-refractory oropharyngeal candidiasis in AIDS: correlation of clinical response with in vitro susceptibility

  1996cited by this paper
• Influence of human serum on the postantifungal effect of four antifungal agents on Candida albicans.

  1996cited by this paper
• [Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].

  1996cited by this paper
• Itraconazol‐Suspension in der Behandlung HIV‐infizierter Patienten mit Fluconazol‐resistenter oropharyngealer Candida‐Infektion und Soorösophagitis

  1996cited by this paper
• Activity of fluconazole: postantifungal effect, effects of low concentrations and of pretreatment on the susceptibility of Candida albicans to leucocytes.

  1994cited by this paper
• The postantibiotic effect of antifungal agents against common pathogenic yeasts.

  1994cited by this paper
• Once versus thrice daily gentamicin in patients with serious infections.

  1993cited by this paper
• The postantibiotic effect.

  1992cited by this paper
• Effect of cyclodextrin on the pharmacology of antifungal oral azoles

  1992cited by this paper
• Turbidometric characterization of the postantifungal effect: comparative studies with amphotericin B, 5‐fluorocytosine and miconazole on Candida albicans

  1991cited by this paper
• Once-daily aminoglycoside therapy

  1991cited by this paper
• The Clinical Pharmacokinetics of Itraconazole: An Overview

  1989cited by this paper
• National Committee for Clinical Laboratory Standards.

  1980cited by this paper

• Therapeutic Drug Monitoring of Itraconazole in Endemic Paracoccidioidomycosis: Real-World Data

  2025cites this paper
• Comparison of various regimens of itraconazole in treatment of acute vulvovaginal candidiasis

  2021cites this paper
• Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts

  2018cites this paper
• Antifungal Therapy in Eye Infections: New Drugs, New Trends

  2016cites this paper
• Thiazole compounds with activity against Cryptococcus gattii and Cryptococcus neoformans in vitro.

  2015cites this paper
• Antifungals In Eye Infections: Drugs And Routes Of Administration

  2013cites this paper
• Miconazole Induces Fungistasis and Increases Killing of Candida albicans Subjected to Photodynamic Therapy †

  2012cites this paper
• Amphotericin B-Induced in vitro Postantifungal Effect on Candida Species of Oral Origin

  2012cites this paper
• Miconazole revisited: new evidence of antifungal efficacy from laboratory and clinical trials.

  2008cites this paper
• イトラコナゾール内用液（イトリゾール®内用液1%）の薬理学的および薬物動態学的特徴ならびに臨床試験成績

  2007cites this paper
• [Pharmacological, pharmacokinetic, and clinical profile of itraconazole oral solution (ITRIZOLE Oral Solution 1%)].

  2007cites this paper
• Oral administration of itraconazole solution has superior efficacy in experimental oral and oesophageal candidiasis in mice than its intragastric administration.

  2006cites this paper